BioCentury
ARTICLE | Politics & Policy

Calif. bill would shine light on drug costs

February 25, 2015 3:03 AM UTC

David Chiu (D-San Francisco) introduced a bill in the California State Assembly that would require the manufacturer of any drug priced higher than $10,000 per year to report operational costs and profits associated with the product. Chiu said the bill is meant to provide transparency as drug prices rise.

The bill would require drugmakers to report profits attributed to drugs as well as expenses for R&D, clinical trials, acquisition, manufacturing, marketing, advertising and patient prescription assistance programs. Companies would also have to report grants associated with high-priced drugs. ...